0

    531681

    AMERISE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    AMERISE BIOSCIENCES LIMITED Share Price Today

    Investment Returns

    Over 1 Month 15.49% Over 3 Months 30.15% Over 6 Months 34.42% Over 1 Year -3.52%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    AMERISE BIOSCIENCES LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 5.40
    • P/E Ratio (TTM) 0.00
    • Beta 0.56
    • Book Value / share 0.81
    • Return on equity 0.17%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.06
    info icon alternate text

    AMERISE BIOSCIENCES LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.02
    Net Profit 0.06
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.01
    EBITDA 0.06
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.04
    Net Profit 0.01
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA 0.01
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.11
    Net Profit -0.04
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.01
    EBITDA -0.04
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.07
    Net Profit -0.01
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA -0.01
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.08
    Net Profit 0.11
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.02
    EBITDA 0.11
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.23
    Net Profit 0.02
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA 0.02
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.18
    Net Profit 0.01
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA 0.01
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.18
    Net Profit -0.15
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.02
    EBITDA -0.15
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.13
    Net Profit -0.12
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.02
    EBITDA -0.12
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 9.01
    Operating Expense 9.03
    Net Profit 0.55
    Net Profit Margin (%) 6.10
    Earnings Per Share (EPS) 0.08
    EBITDA 0.55
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 0.81
    ROE % 0.17
    ROCE % 0.17
    Total Debt to Total Equity 0.00
    EBITDA Margin 5.26
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 0.81
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.01
    EBITDA Margin -375.00
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 0.84
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.02
    EBITDA Margin -1200.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 0.85
    ROE % 9.34
    ROCE % 9.27
    Total Debt to Total Equity 0.01
    EBITDA Margin 5.74
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 0.77
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 8.46
    Total Liabilities 8.46
    Total Equity 5.37
    Share Outstanding 6
    Price to Book Ratio 1.12
    Return on Assets (%) 0.06
    Return on Capital (%) 0.11
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 5.38
    Total Liabilities 5.38
    Total Equity 5.37
    Share Outstanding 6
    Price to Book Ratio 0.81
    Return on Assets (%) -2.71
    Return on Capital (%) -2.72
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 5.64
    Total Liabilities 5.64
    Total Equity 5.52
    Share Outstanding 6
    Price to Book Ratio 0.83
    Return on Assets (%) -2.10
    Return on Capital (%) -2.12
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 11.98
    Total Liabilities 11.98
    Total Equity 5.63
    Share Outstanding 6
    Price to Book Ratio 1.60
    Return on Assets (%) 4.58
    Return on Capital (%) 9.6
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 5.62
    Total Liabilities 5.62
    Total Equity 5.09
    Share Outstanding 6
    Price to Book Ratio 2.14
    Return on Assets (%) -5.99
    Return on Capital (%) -6.62
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.00
    Cash from Operations 3.07
    Cash from Investing -3.06
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow 3.07
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.14
    Cash from Operations -0.16
    Cash from Investing 0.26
    Cash from Financing -0.09
    Net change in Cash 0.00
    Free Cash Flow -0.16
    Particulars MAR 2023 (Values in Cr)
    Net Income -0.11
    Cash from Operations -0.13
    Cash from Investing 0.12
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow -0.13
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.54
    Cash from Operations 0.06
    Cash from Investing -0.15
    Cash from Financing 0.08
    Net change in Cash 0.00
    Free Cash Flow 0.06
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.33
    Cash from Operations -0.39
    Cash from Investing 0.38
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow -0.39
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    KESORAM INDUSTRIES LTD. 11.13 0.00 0.93 345.82 4.58 14.31
    MAX FINANCIAL SERV LTD 1615.80 0.00 10.55 55763.64 1408.05 1891.35
    MODI RUBBER LTD. 133.91 0.00 0.62 335.31 98.41 167.50
    THOMAS COOK (INDIA) LTD. 106.70 22.51 2.57 5018.96 86.15 188.45
    RAIN INDUSTRIES LIMITED 188.90 21.06 0.85 6353.65 99.85 214.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    FGP LTD. 11.62 193.67 4.04 13.82 7.32 12.75
    KESORAM INDUSTRIES LTD. 11.13 9.76 1.00 345.82 4.58 14.31
    MPIL CORPORATION LTD. 559.30 0.00 3.46 31.88 324.70 639.20
    MAX FINANCIAL SERV LTD 1615.80 0.00 8.26 55763.64 1408.05 1891.35

    AMERISE BIOSCIENCES LIMITED shareholding pattern

    Holding
    100.0%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    AMERISE BIOSCIENCES LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    0.82 0.00 redarrow
    red-green-graph indicator
    4 Bearish
    12 Bullish
    • 5 Days 0.80
    • 26 Days 0.00
    • 10 Days 0.00
    • 50 Days 0.80
    • 12 Days 0.00
    • 100 Days 0.70
    • 20 Days 0.80
    • 200 Days 0.00
    0.83 PIVOT
    First Support 0.81 First Resistance 0.85 Second Support 0.79 Second Resistance 0.87 Third Support 0.77 Third Resistance 0.89
    RSI 0.00 ADX 28.28 MACD 0.00 Williams % R -41.38 Commodity Channel Index (CCI) 50.36
    Date 2026-07-02 Week 50675.00 Same Day 32517.00 Month 90089.00
    1 Year 0.56 3 Year 0.57
    Over 1 Month
    15.49% down
    Over 1 Year
    -3.52% down
    Over 3 Months
    30.15% down
    Over 3 Years
    2.11% down
    Over 6 Months
    34.42% down
    Over 5 Years
    -11.37% down

    AMERISE BIOSCIENCES LIMITED Corporate Actions

    Ex-Date Old FV NEW FV Record Date
    18 Nov 2003 10.0 1.0 25 Nov 2003

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Amerise Biosciences Ltd?

    Answer Field

    Amerise Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.82 as on Jul 03 2026 03:15 PM.

    What is the Market Cap of Amerise Biosciences Ltd Share?

    Answer Field

    The market cap of Amerise Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 5.40 as on Jul 03 2026 03:15 PM.

    What is the 52 Week High and Low of Amerise Biosciences Ltd?

    Answer Field

    The 52 Week High and Low of Amerise Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 0.94 and ₹ 0.50.

    What is 1 year return for Amerise Biosciences Ltd?

    Answer Field

    The 1 year returns on the stock has been -3.52%.

    What is the P/E Ratio of Amerise Biosciences Ltd Share?

    Answer Field

    As on Jul 03 2026 03:15 PM the price-to-earnings (PE) ratio for Amerise Biosciences Ltd share is 0.00.

    What is the PB ratio of Amerise Biosciences Ltd Share?

    Answer Field

    As on Jul 03 2026 03:15 PM, the price-to-book (PB) ratio for Amerise Biosciences Ltd share is 0.81.

    How to Buy Amerise Biosciences Ltd Share?

    Answer Field

    You can trade in Amerise Biosciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Amerise Biosciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Amerise Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Amerise Biosciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |